Department of Population Health Sciences, Center for Health Measurement, Duke University School of Medicine, 215 Morris Street, Suite 235, DUMC 104023, Durham, NC 27701, USA.
Division of Pediatric Rheumatology, Department of Pediatrics, Duke University School of Medicine, 2301 Erwin Rd. Durham, NC 27705, USA.
Rheum Dis Clin North Am. 2022 Feb;48(1):15-29. doi: 10.1016/j.rdc.2021.09.008.
For children with pediatric rheumatic diseases (PRDs), the inclusion of patient-reported outcomes (PROs) is critical to inform decision making in health care delivery and research settings. PROs are direct reports from a child on their health status, without interpretation by anyone else. PROs improve understanding of the patient experience, allow clinicians to provide patient-centered care, and add value to clinical trials. When PROs cannot be collected directly from the patient, caregiver-proxy reports can provide important information on the child's more observable symptoms and functioning. In this article, we describe the current use of PROs in specific PRDs, align current research with best practice recommendations for both clinical care and research settings, highlight exciting new developments, and identify areas for future research.
对于患有儿科风湿性疾病 (PRD) 的儿童,纳入患者报告的结果 (PROs) 对于医疗保健提供和研究环境中的决策至关重要。PROs 是儿童对其健康状况的直接报告,无需其他人进行解释。PROs 可以增进对患者体验的理解,使临床医生能够提供以患者为中心的护理,并为临床试验增加价值。当无法直接从患者那里收集 PROs 时,照顾者代理报告可以提供有关儿童更可观察到的症状和功能的重要信息。在本文中,我们描述了 PROs 在特定 PRD 中的当前使用情况,使当前的研究与临床护理和研究环境的最佳实践建议保持一致,突出了令人兴奋的新发展,并确定了未来研究的领域。